SalisamirWill Medicare Push Drug Prices Down in 2024?In the realm of healthcare, a pressing question looms: Will Medicare be the catalyst for lowering drug prices in 2024? As the healthcare…Apr 30
Gregg GirvaninFREOPP.orgPrice Hikes By Large Drug Companies Fail to Drive Medical InnovationNot all R&D spending by the pharmaceutical industry is equally productive. Small companies develop most new medicines.Nov 16, 2022
Vera MucajHealthcare topics at the US state of the UnionYesterday, President Biden delivered the 2024 State of the Union address. As predicted, there were a number of healthcare references…Mar 8Mar 8
World In DataDrugbank — Drug Prices APIThe Drugbank drug price database has the potential to provide valuable insights and information to a wide range of users. By using the API…Dec 27, 2023Dec 27, 2023
Peter KolchinskyinThe Biotech Social ContractAmerica’s Social Contract with the Biopharmaceutical IndustryPeter Kolchinsky, Ph.D.Dec 27, 20179Dec 27, 20179
SalisamirWill Medicare Push Drug Prices Down in 2024?In the realm of healthcare, a pressing question looms: Will Medicare be the catalyst for lowering drug prices in 2024? As the healthcare…Apr 30
Gregg GirvaninFREOPP.orgPrice Hikes By Large Drug Companies Fail to Drive Medical InnovationNot all R&D spending by the pharmaceutical industry is equally productive. Small companies develop most new medicines.Nov 16, 2022
Vera MucajHealthcare topics at the US state of the UnionYesterday, President Biden delivered the 2024 State of the Union address. As predicted, there were a number of healthcare references…Mar 8
World In DataDrugbank — Drug Prices APIThe Drugbank drug price database has the potential to provide valuable insights and information to a wide range of users. By using the API…Dec 27, 2023
Peter KolchinskyinThe Biotech Social ContractAmerica’s Social Contract with the Biopharmaceutical IndustryPeter Kolchinsky, Ph.D.Dec 27, 20179
Congressional CommunitiesFeatured Article: Medicare Drug Price Negotiation (December 20th, 2023)Congressional Communities is featuring one Congressional Research Service (CRS) article per day in effort to share with our readers the…Dec 20, 2023
Peter KolchinskyinThe Biotech Social ContractDirect-to-Consumer (DTC) advertising: misnamed, misunderstood, and underappreciatedMaligned by doctors and often parodied, appropriately regulated direct-to-consumer drug advertising is a net positive for American…Dec 20, 2018
Gregg GirvaninFREOPP.orgMissed Opportunities in Medicare’s Drug Price NegotiationsNegotiations on several of the ten drugs selected will bring limited savings for patients and taxpayers.Oct 20, 2023
